Hyperpigmentation on the face is any area of skin that has become darker than the surrounding tissue due to excess melanin production. It shows up as flat patches, spots, or uneven skin tone and is one of the most common reasons people visit a dermatologist. The darkening itself is harmless, but because it sits on the most visible part of the body, it often drives people to look for answers and treatment options.
How Excess Melanin Forms
Your skin color comes from melanin, a pigment produced by specialized cells called melanocytes. These cells manufacture melanin inside tiny compartments and then transfer it to surrounding skin cells. The process is controlled by a key enzyme called tyrosinase, which acts as the rate-limiting step. When something triggers melanocytes to ramp up tyrosinase activity, melanin production increases and the skin in that area darkens.
Several signals can flip that switch: UV exposure, hormonal shifts, inflammation from a wound or breakout, and even heat. The triggers differ, but the downstream result is the same. More tyrosinase activity means more melanin, and more melanin means a darker patch of skin. This is why most treatments for hyperpigmentation target tyrosinase in one way or another.
The Three Main Types on the Face
Melasma
Melasma appears as larger, often symmetrical patches of darkened skin on the cheeks, forehead, upper lip, and chin. It is strongly tied to hormones. Research published in eLife showed that estrogen at concentrations seen during pregnancy increased melanin production in human melanocytes by roughly 208%. This is why melasma is sometimes called the “mask of pregnancy,” though it also affects people taking hormonal contraceptives or hormone therapy, and it can appear in men. Sun exposure and heat make it worse, and it tends to be chronic, fading and returning with hormonal fluctuations or seasonal UV changes.
Sunspots (Solar Lentigines)
Sunspots are flat, brown patches caused by years of cumulative UV damage. They’re most common on the face, chest, shoulders, and hands. Unlike melasma, they don’t typically fluctuate with hormones or disappear on their own. Each spot represents a cluster of melanocytes that have been permanently upregulated by repeated sun exposure. They tend to multiply and darken with age, which is why they’re sometimes called age spots.
Post-Inflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation (PIH) is the dark mark left behind after acne, eczema, a bug bite, or any injury to the skin. The inflammation triggers a burst of melanin production in the healing area, leaving a spot that can range from pink to deep brown or nearly black depending on skin tone. PIH is not a scar, though it can take 8 to 12 weeks or longer to fade, even with treatment. Without treatment, deeper spots can linger for months or years.
Who Is Most Affected
People with medium to deep skin tones are significantly more prone to hyperpigmentation, particularly PIH. This is because melanocytes in darker skin have higher baseline activity and produce larger, more widely distributed packets of melanin. When the skin is disrupted by acne, eczema, or trauma, inflammatory signals further boost tyrosinase activity, resulting in dark spots that are more pronounced and more persistent than they would be in lighter skin.
This creates a frustrating cycle: the same treatments that help (certain acids, lasers, aggressive exfoliation) can themselves trigger inflammation that causes new dark spots if not used carefully. For this reason, treatment for darker skin tones often needs to be more conservative and gradual.
How a Dermatologist Identifies the Type
A dermatologist can often diagnose hyperpigmentation by visual exam alone, but a tool called a Wood’s lamp helps determine how deep the pigment sits. Under this ultraviolet light, pigment trapped in the upper layer of skin (the epidermis) appears as sharply defined brown or black patches. Pigment lodged deeper in the dermis shows up as unaccentuated grey-blue areas that don’t become more prominent under the light.
This distinction matters because epidermal pigment responds much better to topical treatments. Dermal pigment is harder to reach and typically takes longer to improve, sometimes requiring professional procedures.
Topical Treatments That Work
Most topical treatments target tyrosinase to slow melanin production while your skin naturally sheds the darkened cells above. Because skin cells turn over roughly every four to six weeks, visible improvement from any topical product typically takes a minimum of 8 to 12 weeks of consistent use.
Hydroquinone remains the most widely studied lightening agent. Over-the-counter products contain up to 2%, while prescription formulas go up to 4%. It works by directly inhibiting tyrosinase. Dermatologists generally recommend using it in cycles rather than continuously, to reduce the risk of a rare rebound darkening effect.
Vitamin C, azelaic acid, and niacinamide are common alternatives that work through slightly different pathways, including antioxidant protection and blocking the transfer of melanin to surrounding skin cells. They tend to be gentler and better tolerated by sensitive or darker skin, though they typically work more slowly than hydroquinone.
Cysteamine is a newer option gaining attention. A meta-analysis of six randomized controlled trials found that 5% cysteamine cream significantly improved melasma scores. It works by interfering with the same oxidation process that tyrosinase uses to produce melanin, and it appears to be well tolerated across skin tones.
Retinoids (vitamin A derivatives) speed skin cell turnover, which helps push pigmented cells to the surface faster. They also have a mild effect on melanin production. The trade-off is that retinoids can be irritating, especially in the first few weeks, and that irritation can paradoxically worsen PIH in darker skin if introduced too aggressively.
Why Sunscreen Alone May Not Be Enough
Sun protection is the single most important step in both preventing and treating facial hyperpigmentation. UV radiation directly stimulates melanocytes, and even a few minutes of unprotected exposure can undo weeks of treatment progress. But standard UV-blocking sunscreens may not be sufficient on their own.
Visible light, which makes up nearly half the sunlight spectrum, can also worsen hyperpigmentation, particularly in deeper skin tones. A study in the Journal of Drugs in Dermatology found that over 12 weeks, women with medium to deep skin using SPF 50 plus a tinted formula containing iron oxides saw measurably better results than those using SPF alone. Among the melasma patients, 36% of those in the iron oxide group saw superior gains in skin radiance compared to zero in the SPF-only group.
Iron oxides are the key ingredient here. They block visible light wavelengths that standard sunscreen filters miss. Tinted sunscreens and tinted moisturizers with SPF are the easiest way to get this protection. If you’re actively treating hyperpigmentation, a tinted broad-spectrum sunscreen is a practical upgrade over a non-tinted one.
Professional Procedures
When topical products aren’t enough, dermatologists can offer chemical peels, laser treatments, or microneedling. Chemical peels use concentrated acids to remove the outer layers of skin where pigment is trapped. Superficial peels using 50% glycolic acid or 30% salicylic acid target the epidermis and the junction just below it, making them effective for PIH and mild melasma without penetrating deep enough to cause significant downtime.
Laser treatments can target pigment more precisely, but they carry a higher risk of triggering new hyperpigmentation in darker skin tones. This is why many dermatologists prefer a conservative, layered approach: starting with topicals and sun protection, adding a peel series if needed, and reserving lasers for stubborn cases that haven’t responded to less aggressive options.
Regardless of the method, professional treatments still require the same 8-to-12-week minimum to show full results, and most people need multiple sessions spaced weeks apart. Consistent sun protection between sessions is non-negotiable, since newly treated skin is especially vulnerable to UV-triggered rebound darkening.